Mutations affecting the bone morphogenic protein type 2 (BMPR2) receptor have been associated strongly with hereditary PAH, and BMPR2 has also been linked with other subtypes of PAH, including PAH-CHD. Here, BMPR2 is linked to coronary artery disorder.